These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Current knowledge on cannabinoids in oral fluid. Lee D; Huestis MA Drug Test Anal; 2014; 6(1-2):88-111. PubMed ID: 23983217 [TBL] [Abstract][Full Text] [Related]
23. A systematic review of quantitative analysis of cannabinoids in oral fluid. Gorziza RP; Duarte JA; González M; Arroyo-Mora LE; Limberger RP J Forensic Sci; 2021 Nov; 66(6):2104-2112. PubMed ID: 34405898 [TBL] [Abstract][Full Text] [Related]
24. Determination of methadone in exhaled breath condensate by liquid chromatography-tandem mass spectrometry. Beck O; Sandqvist S; Eriksen P; Franck J; Palmskog G J Anal Toxicol; 2011 Apr; 35(3):129-33. PubMed ID: 21439147 [TBL] [Abstract][Full Text] [Related]
25. Determination of 21 drugs in oral fluid using fully automated supported liquid extraction and UHPLC-MS/MS. Valen A; Leere Øiestad ÅM; Strand DH; Skari R; Berg T Drug Test Anal; 2017 May; 9(5):808-823. PubMed ID: 27464485 [TBL] [Abstract][Full Text] [Related]
26. Quantitation of Cannabinoids in Breath Samples Using a Novel Derivatization LC-MS/MS Assay with Ultra-High Sensitivity. Luo YR; Yun C; Lynch KL J Anal Toxicol; 2019 Jun; 43(5):331-339. PubMed ID: 30951168 [TBL] [Abstract][Full Text] [Related]
27. 11-Nor-9-carboxy-∆9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography-tandem mass spectrometry. Scheidweiler KB; Himes SK; Chen X; Liu HF; Huestis MA Anal Bioanal Chem; 2013 Jul; 405(18):6019-27. PubMed ID: 23681203 [TBL] [Abstract][Full Text] [Related]
28. Metabolic profile of exhaled breath condensate from the pneumonia patients. Li X; Du J; Chen J; Lin F; Wang W; Wei TT; Xu J; Lu QB Exp Lung Res; 2022; 48(4-6):149-157. PubMed ID: 35708062 [TBL] [Abstract][Full Text] [Related]
29. Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS. Rodrigues WC; Catbagan P; Rana S; Wang G; Moore C J Anal Toxicol; 2013 Oct; 37(8):526-33. PubMed ID: 23946452 [TBL] [Abstract][Full Text] [Related]
30. Analytical methodologies for broad metabolite coverage of exhaled breath condensate. Aksenov AA; Zamuruyev KO; Pasamontes A; Brown JF; Schivo M; Foutouhi S; Weimer BC; Kenyon NJ; Davis CE J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():17-25. PubMed ID: 28697414 [TBL] [Abstract][Full Text] [Related]
31. Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure. Blandino V; Wetzel J; Kim J; Haxhi P; Curtis R; Concheiro M Curr Pharm Biotechnol; 2017; 18(10):796-805. PubMed ID: 29173162 [TBL] [Abstract][Full Text] [Related]
32. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine. Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237 [TBL] [Abstract][Full Text] [Related]
33. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry. Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938 [TBL] [Abstract][Full Text] [Related]
34. Determination of XLR-11 and its metabolites in hair by liquid chromatography-tandem mass spectrometry. Park M; Yeon S; Lee J; In S J Pharm Biomed Anal; 2015 Oct; 114():184-9. PubMed ID: 26070160 [TBL] [Abstract][Full Text] [Related]
35. Cannabinoids in exhaled breath following controlled administration of smoked cannabis. Himes SK; Scheidweiler KB; Beck O; Gorelick DA; Desrosiers NA; Huestis MA Clin Chem; 2013 Dec; 59(12):1780-9. PubMed ID: 24046200 [TBL] [Abstract][Full Text] [Related]
36. Online trapping and enrichment ultra performance liquid chromatography-tandem mass spectrometry method for sensitive measurement of "arginine-asymmetric dimethylarginine cycle" biomarkers in human exhaled breath condensate. Di Gangi IM; Pirillo P; Carraro S; Gucciardi A; Naturale M; Baraldi E; Giordano G Anal Chim Acta; 2012 Nov; 754():67-74. PubMed ID: 23140956 [TBL] [Abstract][Full Text] [Related]
37. Simultaneous quantification of terpenes and cannabinoids by reversed-phase LC-APCI-MS/MS in Cannabis sativa L. samples combined with a subsequent chemometric analysis. Raeber J; Poetzsch M; Schmidli A; Favrod S; Steuer C Anal Bioanal Chem; 2024 Jul; 416(18):4193-4206. PubMed ID: 38795214 [TBL] [Abstract][Full Text] [Related]
38. Drug abuse screening with exhaled breath and oral fluid in adults with substance use disorder. Arvidsson M; Ullah S; Franck J; Dahl ML; Beck O Drug Test Anal; 2019 Jan; 11(1):27-32. PubMed ID: 29575801 [TBL] [Abstract][Full Text] [Related]
39. Effect of temperature control on the metabolite content in exhaled breath condensate. Zamuruyev KO; Borras E; Pettit DR; Aksenov AA; Simmons JD; Weimer BC; Schivo M; Kenyon NJ; Delplanque JP; Davis CE Anal Chim Acta; 2018 May; 1006():49-60. PubMed ID: 30016264 [TBL] [Abstract][Full Text] [Related]
40. Simultaneous determination of major phytocannabinoids, their main metabolites, and common synthetic cannabinoids in urine samples by LC-MS/MS. Dong X; Li L; Ye Y; Zheng L; Jiang Y J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():55-64. PubMed ID: 27521533 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]